Family Medicine Doctors in Gothenburg, NE Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Dr. Carol L Shackleton, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 918 20th Street, Gothenburg, NE 69138 Phone: 308-537-7131 Fax: 308-537-7310 |
Kayla S Knauss, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 918 20th St, Gothenburg, NE 69138 Phone: 308-537-4066 Fax: 308-537-4038 |
 Dr. Craig David Bartruff, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 619 10th St, Gothenburg, NE 69138 Phone: 308-537-3674 Fax: 308-537-3675 |
Garret T Shaw, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 918 20th St, Gothenburg, NE 69138 Phone: 308-537-4066 Fax: 308-537-3074 |
News Archive
Gut bacteria composition could predict toxicity of chemotherapy drugs in cancer patients
Albert Einstein College of Medicine researchers report that the composition of people's gut bacteria may explain why some of them suffer life-threatening reactions after taking a key drug for treating metastatic colorectal cancer.
"Leukotriene B4" play opposing roles in turning inflammation on and off for allergic asthma, COPD
Bethesda, MD-Japanese researchers have made a new step toward understanding why-and how to stop-runaway inflammation for both chronic obstructive pulmonary disorder (COPD) and allergic asthma. In a new report appearing in the August 2013 issue of The FASEB Journal scientists show that two receptors of an inflammatory molecule, called "leukotriene B4," play opposing roles in turning inflammation on and off for allergic asthma and COPD.
Mental health visits to emergency departments are increasing among youth and adolescents
While the number of pediatric emergency department (ED) visits across the nation has remained stable over the last 10 years, visits for mental health disorders have risen 60% and the rate of visits for deliberate self-harm have increased 329%.
FDA grants final approval for Mylan's Promethazine HCl Tablets
Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Promethazine Hydrochloride (HCl) Tablets USP, 12.5 mg, 25 mg and 50 mg. Promethazine HCl Tablets are used to relieve the symptoms of certain allergic reactions, such as perennial and seasonal allergic rhinitis.
› Verified 5 days ago